From Disease and Patient Heterogeneity to Precision Medicine in Type 1 Diabetes
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
From Disease and Patient Heterogeneity to Precision Medicine in Type 1 Diabetes
Authors
Keywords
-
Journal
Frontiers in Medicine
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-07-12
DOI
10.3389/fmed.2022.932086
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improving the Prediction of Type 1 Diabetes Across Ancestries
- (2022) John S. Kaddis et al. DIABETES CARE
- Genetic manipulation of stress pathways can protect stem-cell-derived islets from apoptosis in vitro
- (2022) Nayara C. Leite et al. Stem Cell Reports
- Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals
- (2021) Emily K. Sims et al. Science Translational Medicine
- Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2021) Matthias von Herrath et al. Lancet Diabetes & Endocrinology
- Islet-Resident Dendritic Cells and Macrophages in Type 1 Diabetes: In Search of Bigfoot’s Print
- (2021) Henner Zirpel et al. Frontiers in Endocrinology
- Breaking and restoring immune tolerance to pancreatic beta-cells in type 1 diabetes
- (2021) Neslihan Erdem et al. Current Opinion in Endocrinology Diabetes and Obesity
- Defining a cure for type 1 diabetes: a call to action
- (2021) Bart O Roep et al. Lancet Diabetes & Endocrinology
- Function and composition of pancreatic islet cell implants in omentum of type 1 diabetes patients
- (2021) Freya Van Hulle et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Human islet T cells are highly reactive to preproinsulin in type 1 diabetes
- (2021) Amanda M. Anderson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multiple clinically relevant immunotherapies prolong the function of microencapsulated porcine islet xenografts in diabetic NOD mice without the use of anti‐CD154 mAb
- (2020) Susan A. Safley et al. XENOTRANSPLANTATION
- Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis
- (2020) Pia Leete et al. DIABETOLOGIA
- Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study
- (2020) Michelle Rosenzwajg et al. DIABETOLOGIA
- Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes
- (2020) Ulf Hannelius et al. DIABETOLOGIA
- Follicular helper T cell profiles predict response to costimulation blockade in type 1 diabetes
- (2020) Natalie M. Edner et al. NATURE IMMUNOLOGY
- Engineering designer beta cells with a CRISPR-Cas9 conjugation platform
- (2020) Donghyun Lim et al. Nature Communications
- Safety and feasibility of intradermal injection with tolerogenic dendritic cells pulsed with proinsulin peptide—for type 1 diabetes
- (2020) Tatjana Nikolic et al. Lancet Diabetes & Endocrinology
- Immune-evasive human islet-like organoids ameliorate diabetes
- (2020) Eiji Yoshihara et al. NATURE
- Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?)
- (2020) Bart O. Roep et al. Nature Reviews Endocrinology
- Engineering IL-2 to Give New Life to T Cell Immunotherapy
- (2020) Willem W. Overwijk et al. Annual Review of Medicine
- Diabetes relief in mice by glucose-sensing insulin-secreting human α-cells
- (2019) Kenichiro Furuyama et al. NATURE
- Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes
- (2019) Peter J. Thompson et al. Cell Metabolism
- Response to Comment on Sims et al. Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes. Diabetes Care 2019;42:258–264
- (2019) Emily K. Sims et al. DIABETES CARE
- Transplantation of PEGylated islets enhances therapeutic efficacy in a diabetic nonhuman primate model
- (2019) Cherie L. Stabler et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
- (2019) Manuela Battaglia et al. DIABETES CARE
- Clinical and genetic correlates of islet-autoimmune signatures in juvenile-onset type 1 diabetes
- (2019) Laura A. Claessens et al. DIABETOLOGIA
- The Role of the Islet Niche on Beta Cell Structure and Function
- (2019) Eckhard Lammert et al. JOURNAL OF MOLECULAR BIOLOGY
- Compensation of Disabled Organogeneses in Genetically Modified Pig Fetuses by Blastocyst Complementation
- (2019) Hitomi Matsunari et al. Stem Cell Reports
- Strength in Numbers: Opportunities for Enhancing the Development of Effective Treatments for Type 1 Diabetes—The TrialNet Experience
- (2018) Carla J. Greenbaum et al. DIABETES
- A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk
- (2018) Maria J. Redondo et al. DIABETES CARE
- Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1cin New-Onset Type 1 Diabetes
- (2018) Michael J. Haller et al. DIABETES CARE
- Type 1 diabetes
- (2018) Linda A DiMeglio et al. LANCET
- Approaches and advances in the genetic causes of autoimmune disease and their implications
- (2018) Jamie R. J. Inshaw et al. NATURE IMMUNOLOGY
- Verapamil and beta cell function in adults with recent-onset type 1 diabetes
- (2018) Fernando Ovalle et al. NATURE MEDICINE
- Report of the Key Opinion Leaders Meeting on Stem Cell-Derived Beta Cells
- (2018) Jon Odorico et al. TRANSPLANTATION
- Immunological biomarkers for the development and progression of type 1 diabetes
- (2018) Chantal Mathieu et al. DIABETOLOGIA
- Beta cell preservation in patients with type 1 diabetes
- (2018) Tony K. T. Lam et al. NATURE MEDICINE
- Islet Allotransplantation in the Bone Marrow of Patients With Type 1 Diabetes
- (2018) Paola Maffi et al. TRANSPLANTATION
- Association between maternal gluten intake and type 1 diabetes in offspring: national prospective cohort study in Denmark
- (2018) Julie C Antvorskov et al. BMJ-British Medical Journal
- The challenge of modulating β-cell autoimmunity in type 1 diabetes
- (2018) Mark A Atkinson et al. Lancet Diabetes & Endocrinology
- Antigen-based immune modulation therapy for type 1 diabetes: the era of precision medicine
- (2018) Bart O Roep et al. Lancet Diabetes & Endocrinology
- Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes
- (2017) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Autoreactive T cells in type 1 diabetes
- (2017) Alberto Pugliese JOURNAL OF CLINICAL INVESTIGATION
- HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells
- (2017) Germán G Gornalusse et al. NATURE BIOTECHNOLOGY
- Autoimmunity against a defective ribosomal insulin gene product in type 1 diabetes
- (2017) Maria J L Kracht et al. NATURE MEDICINE
- Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes
- (2017) Mohammad Alhadj Ali et al. Science Translational Medicine
- Mitigating Ischemic Injury of Stem Cell-Derived Insulin-Producing Cells after Transplant
- (2017) Gaetano Faleo et al. Stem Cell Reports
- Immunological Balance Is Associated with Clinical Outcome after Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes
- (2017) Kelen C. R. Malmegrim et al. Frontiers in Immunology
- Type 1 diabetes mellitus
- (2017) Anastasia Katsarou et al. Nature Reviews Disease Primers
- Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study
- (2017) Pieter F. de Groot et al. PLoS One
- Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans
- (2016) Tommi Vatanen et al. CELL
- Human islets and dendritic cells generate post-translationally modified islet autoantigens
- (2016) R. J. McLaughlin et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes Pathogenesis
- (2016) Rene J. McLaughlin et al. Current Diabetes Reports
- A roadmap of the generation of neoantigens as targets of the immune system in type 1 diabetes
- (2016) Bart O Roep et al. CURRENT OPINION IN IMMUNOLOGY
- Differential Insulitic Profiles Determine the Extent of β-Cell Destruction and the Age at Onset of Type 1 Diabetes
- (2016) Pia Leete et al. DIABETES
- Expression of Interferon-Stimulated Genes in Insulitic Pancreatic Islets of Patients Recently Diagnosed With Type 1 Diabetes
- (2016) Marcus Lundberg et al. DIABETES
- Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes
- (2016) Sarah J. Richardson et al. DIABETOLOGIA
- Immunogenicity of human embryonic stem cell-derived beta cells
- (2016) Cornelis R. van der Torren et al. DIABETOLOGIA
- Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion
- (2016) T. Delong et al. SCIENCE
- Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression
- (2016) Christian Hundhausen et al. Science Translational Medicine
- Neoantigens and Microenvironment in Type 1 Diabetes: Lessons from Antitumor Immunity
- (2016) Maria J.L. Kracht et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Generation of stem cell-derived β-cells from patients with type 1 diabetes
- (2016) Jeffrey R. Millman et al. Nature Communications
- Proinsulin multi-peptide immunotherapy induces antigen-specific regulatory T cells and limits autoimmunity in a humanized model
- (2015) V. B. Gibson et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- TYK2, a Candidate Gene for Type 1 Diabetes, Modulates Apoptosis and the Innate Immune Response in Human Pancreatic β-Cells
- (2015) Laura Marroqui et al. DIABETES
- Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
- (2015) Richard A. Insel et al. DIABETES CARE
- Impact of disease heterogeneity on treatment efficacy of immunotherapy in Type 1 diabetes: different shades of gray
- (2015) Nicky JC Woittiez et al. Immunotherapy
- Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients
- (2015) Mark R. Rigby et al. JOURNAL OF CLINICAL INVESTIGATION
- Generation of Functional Human Pancreatic β Cells In Vitro
- (2014) Felicia W. Pagliuca et al. CELL
- Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes
- (2014) Sefina Arif et al. DIABETES
- The Effector T Cells of Diabetic Subjects Are Resistant to Regulation via CD4+FOXP3+ Regulatory T Cells
- (2014) A. Schneider et al. JOURNAL OF IMMUNOLOGY
- Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells
- (2014) Alireza Rezania et al. NATURE BIOTECHNOLOGY
- Insulitis in human type 1 diabetes: a comparison between patients and animal models
- (2014) Peter In’t Veld Seminars in Immunopathology
- Rationale and study design of the Adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D): a non-randomised, open label, adaptive dose finding trial
- (2014) F. Waldron-Lynch et al. BMJ Open
- Progress in immune-based therapies for type 1 diabetes
- (2013) M. von Herrath et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Posttranslational Modification of HLA-DQ Binding Islet Autoantigens in Type 1 Diabetes
- (2013) M. van Lummel et al. DIABETES
- Alternative splicing and differential expression of the islet autoantigen IGRP between pancreas and thymus contributes to immunogenicity of pancreatic islets but not diabetogenicity in humans
- (2013) V. Martijn de Jong et al. DIABETOLOGIA
- Genetically Engineered Human Islets Protected From CD8-mediated Autoimmune Destruction In Vivo
- (2013) Arnaud Zaldumbide et al. MOLECULAR THERAPY
- Plasmid-Encoded Proinsulin Preserves C-Peptide While Specifically Reducing Proinsulin-Specific CD8+ T Cells in Type 1 Diabetes
- (2013) B. O. Roep et al. Science Translational Medicine
- Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
- (2013) Agnès Hartemann et al. Lancet Diabetes & Endocrinology
- Immune responses against islet allografts during tapering of immunosuppression - a pilot study in 5 subjects
- (2012) V. A. L. Huurman et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice
- (2012) Tatiana Takiishi et al. JOURNAL OF CLINICAL INVESTIGATION
- Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients
- (2012) Ken T. Coppieters et al. JOURNAL OF EXPERIMENTAL MEDICINE
- GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes Mellitus
- (2012) Johnny Ludvigsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Two Faces of Interferon- in Cancer
- (2011) M. R. Zaidi et al. CLINICAL CANCER RESEARCH
- Long-Term Outcome of Individuals Treated With Oral Insulin: Diabetes Prevention Trial-Type 1 (DPT-1) oral insulin trial
- (2011) K. Vehik et al. DIABETES CARE
- New hope for immune intervention therapy in type 1 diabetes
- (2011) Bart O Roep LANCET
- Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
- (2011) Tihamer Orban et al. LANCET
- Gut Microbiome Metagenomics Analysis Suggests a Functional Model for the Development of Autoimmunity for Type 1 Diabetes
- (2011) Christopher T. Brown et al. PLoS One
- Islet inflammation and CXCL10 in recent-onset type 1 diabetes
- (2010) B. O. Roep et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Simultaneous Detection of Circulating Autoreactive CD8+ T-Cells Specific for Different Islet Cell-Associated Epitopes Using Combinatorial MHC Multimers
- (2010) J. H. Velthuis et al. DIABETES
- Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation
- (2009) D. L. Roelen et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Current Advances and Travails in Islet Transplantation
- (2009) D. M. Harlan et al. DIABETES
- Differences in Baseline Lymphocyte Counts and Autoreactivity Are Associated With Differences in Outcome of Islet Cell Transplantation in Type 1 Diabetic Patients
- (2009) R. Hilbrands et al. DIABETES
- Graves Hyperthyroidism After Stopping Immunosuppressive Therapy in Type 1 Diabetic Islet Cell Recipients With Pretransplant TPO Autoantibodies
- (2009) P. Gillard et al. DIABETES CARE
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
- (2009) Mark D. Pescovitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Allograft-Specific Cytokine Profiles Associate with Clinical Outcome After Islet Cell Transplantation
- (2008) V. A. L. Huurman et al. AMERICAN JOURNAL OF TRANSPLANTATION
- CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope
- (2008) Ania Skowera et al. JOURNAL OF CLINICAL INVESTIGATION
- Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial
- (2008) Kirsti Näntö-Salonen et al. LANCET
- GAD Treatment and Insulin Secretion in Recent-Onset Type 1 Diabetes
- (2008) Johnny Ludvigsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation
- (2008) Volkert A. L. Huurman et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now